Patents by Inventor Russell C. Petter

Russell C. Petter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HCV PROTEASE INHIBITORS AND USES THEREOF
    Publication number: 20120190614
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Application
    Filed: April 10, 2012
    Publication date: July 26, 2012
    Applicant: AVILA THERAPEUTICS, INC.
    Inventors: Deqiang Niu, Russell C. Petter, Lixin Qiao, Juswinder Singh
  • HETEROARYL COMPOUNDS AND USES THEREOF
    Publication number: 20120149722
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Application
    Filed: October 31, 2011
    Publication date: June 14, 2012
    Applicant: AVILA THERAPEUTICS, INC.
    Inventors: Kwangho Lee, Deqiang Niu, Russell C. Petter, Juswinder Singh
  • HETEROCYCLIC COMPOUNDS AND USES THEREOF
    Publication number: 20120149687
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Application
    Filed: October 31, 2011
    Publication date: June 14, 2012
    Applicant: AVILA THERAPEUTICS, INC.
    Inventors: Kwangho Lee, Deqiang Niu, Russell C. Petter, Matthew F. Baevsky, Juswinder Singh
  • HCV protease inhibitors and uses thereof
    Patent number: 8188137
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Grant
    Filed: August 14, 2009
    Date of Patent: May 29, 2012
    Assignee: Avila Therapeutics, Inc.
    Inventors: Deqiang Niu, Russell C. Petter, Lixin Qiao, Juswinder Singh
  • POLYALKYLENE POLYMER COMPOUNDS AND USES THEREOF
    Publication number: 20120014916
    Abstract: The invention relates to novel polyalkylene glycol compounds and methods of using them. In particular, compounds comprising a novel polyethylene glycol conjugate are used alone, or in combination with antiviral agents to treat a viral infection, such as chronic hepatitis C.
    Type: Application
    Filed: September 12, 2011
    Publication date: January 19, 2012
    Inventors: KoChung Lin, R. Blake Pepinsky, Ling Ling Chen, Donna M. Hess, Edward Y. Lin, Russell C. Petter, Darren P. Baker
  • LIGAND-DIRECTED COVALENT MODIFICATION OF PROTEIN
    Publication number: 20110269244
    Abstract: The present invention relates to enzyme inhibitors. More specifically, the present invention relates to ligand-directed covalent modification of proteins; method of designing same; pharmaceutical formulation of same; and method of use.
    Type: Application
    Filed: December 30, 2010
    Publication date: November 3, 2011
    Inventors: Russell C. Petter, Charles F. Jewell, Kwangho Lee, Aravind Prasad Medikonda, Deqiang Niu, Lixin Qiao, Juswinder Singh, Zhendong Zhu
  • HETEROARYL COMPOUNDS AND USES THEREOF
    Publication number: 20110230494
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Application
    Filed: February 1, 2011
    Publication date: September 22, 2011
    Applicant: AVILA THERAPEUTICS, INC.
    Inventors: Juswinder Singh, Shomir Ghosh, Arthur F. Kluge, Russell C. Petter, Richland W. Tester
  • PI3 KINASE INHIBITORS AND USES THEREOF
    Publication number: 20110230476
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Application
    Filed: September 9, 2010
    Publication date: September 22, 2011
    Applicant: AVILA THERAPEUTICS, INC.
    Inventors: DEQIANG NIU, RUSSELL C. PETTER, JUSWINDER SINGH, ARTHUR F. KLUGE, HORMOZ MAZDIYASNI, ZHENDONG ZHU, LIXIN QIAO, KEVIN KUNTZ
  • HETEROARYL COMPOUNDS AND USES THEREOF
    Publication number: 20110224432
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Application
    Filed: February 1, 2011
    Publication date: September 15, 2011
    Applicant: AVILA THERAPEUTICS, INC.
    Inventors: Juswinder Singh, Shomir Ghosh, Arthur F. Kluge, Russell C. Petter, Richland W. Tester
  • Polyalkylene polymer compounds and uses thereof
    Patent number: 8017733
    Abstract: The invention relates to novel polyalkylene glycol compounds and methods of using them. In particular, compounds comprising a novel polyethylene glycol conjugate are used alone, or in combination with antiviral agents to treat a viral infection, such as chronic hepatitis C.
    Type: Grant
    Filed: July 16, 2004
    Date of Patent: September 13, 2011
    Assignee: Biogen Idec MA Inc.
    Inventors: KoChung Lin, R. Blake Pepinsky, Ling Ling Chen, Donna M. Hess, Edward Y. Lin, Russell C. Petter, Darren P. Baker
  • 4,6-disubstituted pyrimidines useful as kinase inhibitors
    Patent number: 7989465
    Abstract: The present invention provides 4,6-disubstituted pyrimidine compounds useful as kinase inhibitors, pharmaceutically acceptable salts and compositions thereof, and methods of using the same. The present invention also provides probe compounds, such as compounds of formula V: wherein each of Ring A, Ring B, R1?, T, Rt, m, Rx, Ry, and W is described herein.
    Type: Grant
    Filed: April 20, 2009
    Date of Patent: August 2, 2011
    Assignee: Avila Therapeutics, Inc.
    Inventors: Juswinder Singh, Shomir Ghosh, Arthur F. Kluge, Russell C. Petter, Richland W. Tester
  • 4,6-disubstitued pyrimidines useful as kinase inhibitors
    Patent number: 7982036
    Abstract: The present invention provides compounds of formula I wherein Ring A, Ring B, m, Rx, Ry, W and R1 are as defined herein, pharmaceutically acceptable salts and compositions thereof, and methods of using the same.
    Type: Grant
    Filed: October 17, 2008
    Date of Patent: July 19, 2011
    Assignee: Avila Therapeutics, Inc.
    Inventors: Juswinder Singh, Shomir Ghosh, Arthur F. Kluge, Russell C. Petter, Richland W. Tester
  • Polyal Drug Conjugates Comprising Variable Rate-Releasing Linkers
    Publication number: 20100305149
    Abstract: Polyal-Drug conjugates comprising a variable rate-releasing linker are described along with methods of making such conjugates. Uses for such Polyal-Drug conjugates is also described.
    Type: Application
    Filed: May 27, 2010
    Publication date: December 2, 2010
    Applicant: Mersana Therapeutics, Inc.
    Inventors: Aleksandr Yurkovetskiy, Mao Yin, Gui Liu, Laura C. Akullian, John J. Kane, Cheri A. Stevenson, Charles E. Hammond, Russell C. Petter, John H. Van Duzer, Timothy B. Lowinger
  • Aadenosine receptor antagonists
    Patent number: 7834014
    Abstract: The invention is based on the discovery that compounds of formula (I) possess unexpectedly high affinity for the A2a adenosine receptor, and can be useful as antagonists thereof for preventing and/or treating numerous diseases, including Parkinson's disease. In one embodiment, the invention features a compound of formula (I).
    Type: Grant
    Filed: April 9, 2004
    Date of Patent: November 16, 2010
    Assignee: Biogen Idec MA Inc.
    Inventors: Hairuo Peng, Gang Yao, Russell C. Petter, Gnanasambandam Kumaravel
  • PHARMACEUTICAL FORMULATIONS OF BIODEGRADABLE BIOCOMPATIBLE CAMPTOTHECIN-POLYMER CONJUGATES
    Publication number: 20100179181
    Abstract: A camptothecin/polymer dual phase drug release system is described that is stable in both liquid and lyophilized states. The polymer contains acetals and/or ketals.
    Type: Application
    Filed: December 10, 2009
    Publication date: July 15, 2010
    Applicant: Mersana Therapeutics, Inc.
    Inventors: James ROLKE, Russell C. PETTER, Mao YIN, Aleksandr YURKOVETSKIY, Gui LIU, Emile FARHAN
  • HCV PROTEASE INHIBITORS AND USES THEREOF
    Publication number: 20100069294
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Application
    Filed: July 2, 2009
    Publication date: March 18, 2010
    Applicant: Avila Therapeutics, Inc.
    Inventors: Russell C. Petter, Juswinder Singh, Arthur F. Kluge, Deqiang Niu, Lixin Qiao, Shomir Ghosh
  • Triazolopyrazines and methods of making and using the same
    Patent number: 7674791
    Abstract: The invention is based on the discovery that compounds of formula (I) possess unexpectedly high affinity for the A2a adenosine receptor, and can be useful as antagonists thereof for preventing and/or treating numerous diseases, including Parkinson's disease.
    Type: Grant
    Filed: April 9, 2004
    Date of Patent: March 9, 2010
    Assignee: Biogen IDEC MA Inc.
    Inventors: James E. Dowling, Gang Yao, Hexi Chang, Hairuo Peng, Jeffrey Vessels, Russell C. Petter, Gnanasambandam Kumaravel
  • HCV PROTEASE INHIBITORS AND USES THEREOF
    Publication number: 20100041591
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Application
    Filed: July 2, 2009
    Publication date: February 18, 2010
    Applicant: Avila Therapeutics, Inc.
    Inventors: Deqiang Niu, Russell C. Petter, Juswinder Singh, Arthur F. Kluge, Lixin Qiao
  • HCV PROTEASE INHIBITORS AND USES THEREOF
    Publication number: 20100041674
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Application
    Filed: August 14, 2009
    Publication date: February 18, 2010
    Applicant: Avila Therapeutics, Inc.
    Inventors: Deqiang Niu, Russell C. Petter, Lixin Qiao, Juswinder Singh
  • HETEROARYL COMPOUNDS AND USES THEREOF
    Publication number: 20100016296
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Application
    Filed: April 20, 2009
    Publication date: January 21, 2010
    Applicant: Avila Therapeutics, Inc.
    Inventors: Juswinder Singh, Shomir Ghosh, Arthur F. Kluge, Russell C. Petter, Richland W. Tester